Sunday, April 18, 2021 |

Biden administration puts Johnson & Johnson in charge of Emergent’s Baltimore vaccine facility

April 6, 2021

The Biden administration has placed Johnson & Johnson Inc. in charge of Covid-19 vaccine manufacturing at a Baltimore facility belonging to Emergent BioSolutions Inc. following a snafu where as many as 15 million vaccine doses were ruined as a result of human error. Emergent (NYSE: EBS), which is headquartered in Gaithersburg, is a manufacturing partner for both Johnson & Johnson (NYSE: JNJ) and AstraZeneca PLC (NASDAQ: AZN) on Covid vaccines. It was revealed last week Emergent mixed up ingredients for the two vaccines, which were both being manufactured at the Baltimore facility.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.